Table 3.

Characterization of tumor for newly diagnosed glioblastoma patients

Patient ID	Ag expression on tumor (peptide HLA restriction)							Biomarker characterization
	HLA type	AIM2 (A1)	gp100 (A1)	MAGE (A2)	TRP-2 (A2)	HER2 (A2)	ILRa2 (A2)	MGMT	PTEN
2	A2+	+	+	+	+	+	+	UnMet	RETAINED
4	A1+	+	+	+	+	+	+	UnMet	N/A
6	A2+	+	+	Wk	+	+	+	Met	RETAINED
7	A2+	+	+	+	+	+	+	Met	LOSS
9	A2+	+	+	−	+	−	+	Met	RETAINED
10	A2+	+	+	Wk	+	+	+	INV	RETAINED
11	A2+	+	+	+	+	+	+	UnMet	LOSS
12	A2+	+	+	Wk	+	+	+	UnMet	RETAINED
13	A1+	+	Wk	Wk	+	+	+	NT	LOSS
14	A1+	+	+	−	+	+	+	NT	LOSS
15	A1+	+	−	+	+	+	+	INV	RETAINED
16	A1 + A2+	+	+	Wk	+	+	+	Met	LOSS
17	A2+	+	−	Wk	−	+	−	NT	LOSS
18	A1+	+	Wk	Wk	+	+	+	NT	LOSS
19	A2+	+	+	Wk	+	+	+	Met	RETAINED
20	A2+	+	+	Wk	+	+	+	Met	RETAINED

Positive (+), negative (−), weak (Wk)

UnMet unmethylated, Met methylated, INV invalid results, NT not tested